People: AstraZeneca PLC (AZN.L)
13 Dec 2013
Dr. Bruce Burlington is Non-Executive Independent Director of AstraZeneca Plc. Bruce is a pharmaceutical product development and regulatory affairs consultant and brings experience in those areas to the Board. He is also a non-executive board member of Cangene Corporation and a member of the scientific advisory boards of the International Medical Foundation and H. Lundbeck A/S. Previously he spent 17 years with the FDA, serving as director of the FDA’s Center for Devices and Radiological Health as well as holding a number of senior roles in the Center for Drug Evaluation and Research. After leaving the FDA he served in a series of senior executive positions at Wyeth (now part of Pfizer).
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|